Alcohol-HIV/AIDS Program Project (P01 Clinical Trial Optional) | RFA AA 19 002

Opportunity Information: Apply for RFA AA 19 002

The Alcohol-HIV/AIDS Program Project (P01 Clinical Trial Optional) funding opportunity (RFA AA 19 002) is a discretionary NIH grant run through the National Institute on Alcohol Abuse and Alcoholism (NIAAA). Its core purpose is to support coordinated, multi-project research that connects alcohol-related science to practical, real-world approaches for reducing HIV infection and transmission. The emphasis is on research that can be translated into interventions, meaning the funded work should be positioned to inform or produce strategies, programs, or clinical/public health approaches that measurably lower HIV risk, improve prevention outcomes, or reduce onward transmission in populations affected by alcohol use. This objective aligns with broader federal HIV research priorities described in the FY2013 Trans-NIH Plan for HIV-Related Research.

This opportunity uses the NIH P01 Program Project Grant mechanism, which typically supports a set of linked research projects organized around a unifying theme, often sharing common resources, cores, or infrastructure. The "Clinical Trial Optional" designation indicates that the application may include a clinical trial but does not have to; applicants can propose either clinical trial research or non-trial research as long as the overall program clearly advances the alcohol and HIV/AIDS intervention-related goals described in the announcement.

Eligible applicants span a wide range of organization types. Public-sector applicants include state, county, city/township, and special district governments, as well as independent school districts and public housing authorities/Indian housing authorities. Higher education institutions are eligible, including public/state-controlled and private institutions. Tribal eligibility includes federally recognized Native American tribal governments and Native American tribal organizations that are not federally recognized. The opportunity also allows participation from nonprofit organizations (both with and without 501(c)(3) status) and from for-profit organizations other than small businesses, as well as small businesses. In addition, the announcement explicitly highlights other eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs). Faith-based and community-based organizations and eligible federal agencies are also included among eligible applicants, and U.S. territories or possessions may apply as well.

The funding opportunity draws a clear line on foreign eligibility. Non-domestic (non-U.S.) entities and non-domestic (non-U.S.) institutions are not eligible to apply, and non-domestic components of U.S. organizations are also not eligible to apply. At the same time, it allows "foreign components" as defined under the NIH Grants Policy Statement, meaning certain parts of the work may be conducted abroad under an eligible U.S.-based applicant when NIH policy conditions are met, even though a foreign institution cannot serve as the applicant organization.

From the posted source details, the opportunity is listed under CFDA 93.273, with an original closing date of April 16, 2019, and a creation date of November 27, 2018. The record shows an award ceiling of $100,000, although NIH program project grants often involve budgets governed by the specific FOA and NIH budget rules, so applicants generally verify budget limits directly in the full FOA text and related NIH guidance. Overall, the announcement is aimed at driving collaborative, intervention-oriented alcohol and HIV/AIDS research that advances national HIV prevention and transmission reduction goals while engaging a broad set of eligible U.S.-based institutions and organizations.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "Alcohol-HIV/AIDS Program Project (P01 Clinical Trial Optional)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.273.
• This funding opportunity was created on 2018-11-27.
• Applicants must submit their applications by 2019-04-16. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $100,000.00 in funding.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for RFA AA 19 002

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: